What is Goolsby & Associates?
Goolsby & Associates is a prominent provider of Transcranial Magnetic Stimulation (TMS) therapy, operating primarily in Georgia. Since its inception in 1987, the organization has focused on treating conditions such as major depression and anxiety. The practice leverages experienced professionals and innovative TMS treatments to enhance patient quality of life, offering a supportive environment for psychiatric care.
How much funding has Goolsby & Associates raised?
Goolsby & Associates has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Goolsby & Associates
PPP
Public-Private Partnership
What's next for Goolsby & Associates?
The company's large-scale late-stage funding context suggests a strategic phase of expansion and operational enhancement. This substantial capital infusion is likely to fuel further development of its TMS therapy services, potentially broadening its reach within Georgia and enhancing its treatment protocols. The focus on strategic investment indicates a move towards solidifying market leadership and potentially exploring new therapeutic avenues within mental health.
See full Goolsby & Associates company page